Shigehiro Nagasawa
Iizuka, 8208505, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Diagnostic features of autoimmune hepatitis in SARS‑CoV‑2‑vaccinated vs. unvaccinated individuals.
Journal: Experimental and therapeutic medicine
Published: March 20, 2024
Similar Efficacy Between Atezolizumab Plus Bevacizumab Versus Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study.
Journal: In vivo (Athens, Greece)
Published: February 22, 2024
Systemic Chemotherapy for Advanced Hepatocellular Carcinoma in Patients With Child-Pugh class B.
Journal: Cancer diagnosis & prognosis
Published: November 21, 2023
Neutrophil-to-Lymphocyte Ratio Predicts Immune-related Adverse Events in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Journal: Cancer diagnosis & prognosis
Published: September 29, 2023
Combined Ultrasound and Computed Tomography Guidance in Radiofrequency Ablation for Hepatocellular Carcinoma Reduces Local Recurrence Rate.
Journal: Cancer diagnosis & prognosis
Published: August 14, 2023
Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma.
Journal: Internal medicine (Tokyo, Japan)
Published: November 03, 2022
A case of multiple osteonecrosis caused by acute-on-chronic pancreatitis
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Published: August 09, 2022
Hepatitis C virus eradication ameliorates the prognosis of advanced hepatocellular carcinoma treated with sorafenib.
Journal: Journal of viral hepatitis
Published: January 17, 2022
A case of pembrolizumab-induced sclerosing cholangitis that was responsive to high-dose steroid therapy
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Published: October 11, 2021
Therapeutic efficacy of lenvatinib for hepatocellular carcinoma with iso-high intensity in the hepatobiliary phase of Gd-EOB-DTPA-MRI.
Journal: Molecular and clinical oncology
Published: October 07, 2021
Serum α-fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct-acting antiviral treatment.
Journal: Journal of viral hepatitis
Published: August 18, 2021
Last Updated: 09/26/2026